TRELEGY (fluticasone furoate, umeclidinium, and vilanterol inhalation powder)

  • Home
  • TRELEGY (fluticasone furoate, umeclidinium, and vilanterol inhalation powder)

TRELEGY (fluticasone furoate, umeclidinium, and vilanterol inhalation powder) You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

The shape of the ELLIPTA inhaler is a trademark of the GSK group of companies. Trademarks are owned by or licensed to the GSK group of companies.
©2023 GSK or licensor. FVUOGM230053 September 2023
Produced in USA. This material is intended for US residents only.

Address


Website

Alerts

Be the first to know and let us send you an email when TRELEGY (fluticasone furoate, umeclidinium, and vilanterol inhalation powder) posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

  • Want your practice to be the top-listed Clinic?

Share